David M. DeMedio
No más puestos en curso
Perfil
Mr. David M.
DeMedio, CPA, is Chief Services Officer at USA Technologies, Inc.
Mr. DeMedio also served on the board at Gammacan International, Inc.
He received his undergraduate degree from the Shippensburg University of Pennsylvania.
Antiguos cargos conocidos de David M. DeMedio.
| Empresas | Cargo | Fin |
|---|---|---|
| CANTALOUPE, INC. | Director Financiero/CFO | 31/08/2015 |
Gammacan International, Inc.
 Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Director/Miembro de la Junta | 17/09/2008 |
Formación de David M. DeMedio.
| Shippensburg University of Pennsylvania | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CANTALOUPE, INC. | Finance |
| Empresas privadas | 1 |
|---|---|
Gammacan International, Inc.
Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Health Technology |
- Bolsa de valores
- Insiders
- David M. DeMedio